Eosinophil-derived neurotoxin as a biomarker for disease severity and relapse in recalcitrant atopic dermatitis.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Annals of Allergy, Asthma & Immunology

• Publication date

  2017-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.anai.2017.06.022PMID 28866306
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum clusterin level in children with atopic dermatitis.

  2016cited by this paper
• Toxicity of eosinophil MBP is repressed by intracellular crystallization and promoted by extracellular aggregation.

  2015cited by this paper
• Plasma endothelin-1 levels during exacerbation of atopic dermatitis.

  2015cited by this paper
• A panel of biomarkers for disease severity in atopic dermatitis

  2015cited by this paper
• Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): association with clinical severity and phenotype.

  2015cited by this paper
• Retrospective Review of Relapse after Systemic Cyclosporine in Children with Atopic Dermatitis

  2015cited by this paper
• Th17 cells and tissue remodeling in atopic and contact dermatitis

  2014cited by this paper
• Extracellular DNA traps in allergic, infectious, and autoimmune diseases

  2013cited by this paper
• Effect of cyclosporine on lymphocytic variant hypereosinophilic syndrome.

  2013cited by this paper
• Targeting eosinophils in allergy, inflammation and beyond

  2013cited by this paper
• Eosinophil extracellular DNA traps: molecular mechanisms and potential roles in disease.

  2012cited by this paper
• Eosinophils and disease pathogenesis.

  2012cited by this paper
• Thymic stromal lymphopoietin stimulates the formation of eosinophil extracellular traps

  2012cited by this paper
• Correlations of serum Interleukin-16, total IgE, eosinophil cationic protein and total eosinophil counts with disease activity in children with atopic dermatitis.

  2011cited by this paper
• Correlations of Serum Interleukin-16, Total IgE, Eosinophil Cationic Protein and Total Eosinophil Counts with Disease Activity in Children with Atopic Dermatitis

  2011cited by this paper
• Distinct eosinophil cytokine expression patterns in skin diseases – the possible existence of functionally different eosinophil subpopulations

  2011cited by this paper
• IgE, Mast Cells, and Eosinophils in Atopic Dermatitis

  2011cited by this paper
• Practical approach to the patient with hypereosinophilia.

  2010cited by this paper
• Serum eosinophil-derived neurotoxin in childhood atopic dermatitis: a useful marker of disease activity?

  2009cited by this paper
• Urinary eosinophil-derived neurotoxin concentrations in patients with atopic dermatitis: a useful clinical marker for disease activity.

  2007cited by this paper
• Eosinophil trans-basement membrane migration induced by interleukin-8 and neutrophils.

  2006cited by this paper
• Increased serum thymus and activation‐regulated chemokine and cutaneous T cell‐attracting chemokine levels in children with atopic dermatitis

  2006cited by this paper
• Expansion of activated eosinophils in infants with severe atopic dermatitis

  2005cited by this paper
• Eosinophil function in allergic inflammation: From bone marrow to tissue response

  2004cited by this paper
• Eosinophil granule proteins in the assessment of airway inflammation in pediatric bronchial asthma

  2003cited by this paper
• Low‐dose cyclosporin A microemulsion in children with severe atopic dermatitis: Clinical and immunological effects

  2001cited by this paper
• Tissue eosinophilia in acute and chronic atopic dermatitis: a morphometric approach using quantitative image analysis of immunostaining

  2001cited by this paper
• IL-8 Induces a Transient Arrest of Rolling Eosinophils on Human Endothelial Cells1

  2001cited by this paper
• Synergistic effects of interleukin-4 or interleukin-13 and tumor necrosis factor-alpha on eosinophil activation in vitro.

  1999cited by this paper
• Differential effects of the T helper cell type 2-derived cytokines IL-4 and IL-5 on ligand binding to IgG and IgA receptors expressed by human eosinophils.

  1997cited by this paper
• Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis

  1992cited by this paper
• Allergy in subjects with asthma from childhood to adulthood.

  1990cited by this paper
• Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis.

  1985cited by this paper
• Clinical aspects of eosinophilia in atopic disease.

  1967cited by this paper

• Biomarkers for therapeutic response and adverse outcomes in atopic dermatitis: A systematic review.

  2026cites this paper
• Eosinophilic proteins and neuropeptides, cytokine profile in children with atopic dermatitis and chronic gastroduodenitis

  2026cites this paper
• Eosinophil recruitment and activation in the central nervous system of patients with subarachnoid neurocysticercosis

  2025cites this paper
• Integrated Multi-Omics Analyses Reveal Innovative Diagnostic and Therapeutic Targets Associated with Atopic Dermatitis

  2025cites this paper
• From Itchy Skin to Wheezing: Potential biomarkers and targeted drugs for Atopic Dermatitis and Asthma in Children.

  2025cites this paper
• A multidimensional analysis of prognostic factors in atopic dermatitis

  2025cites this paper
• Could altered red cell indices reflect oxidative stress in pediatric atopic dermatitis?

  2025cites this paper
• The search for blood biomarkers useful in treating atopic dermatitis patients

  2024cites this paper
• Eosinopenia in patients with acute myocardial infarction- longitudinal imaging insights from the CAPRI study

  2024cites this paper
• Biomarkers for phenotype-endotype relationship in atopic dermatitis: a critical review

  2024cites this paper
• Retracing from Outcomes to Causes: NRF2-Driven GSTA4 Transcriptional Regulation Controls Chronic Inflammation and Oxidative Stress in Atopic Dermatitis Recurrence.

  2024cites this paper
• Immunopathogenesis of Atopic Dermatitis: Focus on Interleukins as Disease Drivers and Therapeutic Targets for Novel Treatments

  2023cites this paper
• Blood-Based Biomarkers for Eosinophilic Esophagitis and Concomitant Atopic Diseases: A Look into the Potential of Extracellular Vesicles

  2023cites this paper
• A Retrospective Analysis of Risk Factors for Atopic Dermatitis Severity

  2023cites this paper
• Eosinophil granule proteins as a biomarker in managing asthma and allergies

  2023cites this paper
• Serum Levels of Eosinophil-Derived Neurotoxin, Platelet-Activating Factor and Vascular Endothelial Growth Factor in Adult Patients with Atopic Dermatitis—A Pilot Study

  2022cites this paper
• Urine eosinophil‐derived neurotoxin: A potential marker of activity in select eosinophilic disorders

  2022cites this paper
• Serum Levels of Vascular Endothelial Growth Factor, Platelet Activating Factor and Eosinophil-Derived Neurotoxin in Chronic Spontaneous Urticaria—A Pilot Study in Adult Patients

  2022cites this paper
• The role of human ribonuclease A family in health and diseases: A systematic review

  2022cites this paper
• Potential biomarkers of atopic dermatitis

  2022cites this paper
• Atopic dermatitis: an expanding therapeutic pipeline for a complex disease

  2021cites this paper
• Serum Levels of Eosinophil-derived Neurotoxin in Patients with Chronic Urticaria.

  2020cites this paper
• Mild atopic dermatitis lacks systemic inflammation, and shows reduced non-lesional skin abnormalities.

  2020cites this paper
• Synergy of Interleukin (IL)-5 and IL-18 in eosinophil mediated pathogenesis of allergic diseases.

  2019cites this paper
• Atopic Dermatitis: From Physiopathology to the Clinics

  2019cites this paper
• Replicated methylation changes associated with eczema herpeticum and allergic response

  2019cites this paper
• Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches

  2019cites this paper
• Atopic dermatitis: More than a rash.

  2018cites this paper
• The Correlation between SCORAD Index and Serum Total IgE or Eosinophil Count in Individual Patients of Atopic Dermatitis

  2018cites this paper
• [Mexican consensus on the diagnosis and treatment of atopic dermatitis in adolescents and adults].

  2018cites this paper
• Eosinophil-derived neurotoxin enhances airway remodeling in eosinophilic chronic rhinosinusitis and correlates with disease severity

  2018cites this paper
• Expressions of Eotaxin-3, Interleukin-5, and Eosinophil-Derived Neurotoxin in Chronic Subdural Hematoma Fluids

  2018cites this paper